Citations

Showing 10 of 108081 citations.

3D Printed Models of Trochlear Dysplasia and Trochleoplasty Simulation for Trainee Education
Wentworth, Adam, Duit, Andrew, Yu, Kristin E. , Wentworth, Adam J, Morris, Jonathan M. , Hevesi, Mario

Mayo Clinic

Arthroscopy Techniques | April 24, 2023 | Volume: 12 | Issue: 5 | Pages: No page available

10.1016/j.eats.2023.02.004 | PMID 37323795 Get It

Abstract Trochlear dysplasia is a major contributor to patellofemoral instability and subsequent failure of isolated soft tissue reconstruction procedures in the treatment of recurrent patellar dislocation and/or subluxation. Trochleoplasty procedures aim to address abnormal osseous trochlear morphologic factors that contribute to patellar maltracking. However, teaching these techniques is limited by the lack of reliable training models for trochlear dysplasia and trochleoplasty simulation. Although a cadaveric knee model of trochlear dysplasia for trochleoplasty simulation has been recently described, cadaveric knees are less amenable for use in trochleoplasty planning and surgeon training because of the absence of reliable, natural dysplastic anatomic relationships, such as suprapatellar spurs due to the rarity of dysplastic cadavers and the high cost of cadaveric specimens. Furthermore, readily available sawbone models represent “normal” osseous trochlear morphology and are difficult to modify and bend due to their material composition. Given this, we have developed a cost‐effective, reliable, and anatomically accurate three‐dimensional (3D) knee model of trochlear dysplasia for trochleoplasty simulation and trainee education. Technique Video video See video under supplementary data.
Age, Hypertension, and Exercise Capacity are Independently Associated with Likelihood of Multi-Vessel Disease in Patients Referred for Treadmill Exercise Testing: The Intermediate-High-Workload Treadmill Score (IHWTS)
Calle, Maria C. Arciniegas, Abbasi, Muhannad , Bello, Laura B. Garcia, Bonikowske, Amanda R. , Villarraga, Hector R. , Abbasi, Muhannad Aboud , Salah, Husam M, Salah, Husam M. , Scott, Christopher G.

Mayo Clinic

Reviews in Cardiovascular Medicine | April 24, 2023 | Volume: 24 | Issue: 4 | Pages: No page available

10.31083/j.rcm2404108 | PMID 39076284 Get It

Background: To identify factors that increase the specificity of the treadmill exercise test (TMET), and develop a novel scoring system which accounts for functional capacity to aid in determining the need for further testing. Methods: We retrospectively evaluated the electronic health records of 600 patients who had positive TMET results and follow-up stress echocardiography from 1-January-2004, through 31-December-2016. Correlations between clinical and aerobic variables and multivessel disease (MVD) were determined. Duke Treadmill Score (DTS) was calculated and compared with a novel scoring system titled the Intermediate-High-Workload Treadmill Score (IHWTS) that used variables associated with MVD. Results: In total, 124 of 600 patients (21%) had coronary catheterization, and 51 of these patients (41%) had MVD. Mean (SD) DTS was –2.10 (6.3) among patients with MVD vs –0.16 (5) among patients without MVD (p = 0.06). Mean (SD) functional aerobic capacity (FAC) was 76% (20%) among patients with MVD vs 90% (21%) among patients without MVD (p < 0.001). Mean (SD) metabolic equivalent (MET) was 7 (2) among patients with MVD vs 8 (2) among patients without MVD (p = 0.002). Only 6 (12%) of patients with MVD achieved 9 MET or greater on TMET. DTS less than 4 did not distinguish between patients with and without MVD (p = 0.67). Age, hypertension and FAC were independently associated with MVD (all p < 0.05). Conclusions: Our novel scoring system IHWTS utilized age, hypertension, and FAC appeared comparable to DTS to risk-stratify patients regardless of baseline symptoms. Clinical parameters such as hypertension along with exercise functional capacity should be considered when evaluating a positive TMET result in patients that achieve an intermediate-high workload >5 Metabolic Equivalents (METs).
Efficacy of RestoreX after prostatectomy: open‐label phase of a randomized controlled trial
Zganjar, Andrew , Toussi, Amir , Ziegelmann, Matthew , Frank, Igor, Boorjian, Stephen A. , Tollefson, Matthew K. , Köhler, Tobias , Trost, Landon , Tollefson, Matthew

Mayo Clinic

BJU International | April 23, 2023 | Volume: 132 | Issue: 2 | Pages: 217-226

10.1111/bju.16033 | PMID 37088866 Get It

Objective To report open‐label phase data from a recent randomized controlled trial (RCT), after previous data from that study showed improved penile length and erectile function among post‐prostatectomy men treated with Restorex penile traction therapy (RxPTT). Materials and Methods An RCT (NCT05244486) was performed to evaluate RxPTT vs no treatment (Tx) for 5 months, which was followed by a 3‐month open‐label phase. Men were stratified based on as‐treated data: Group 1 = No Tx; Group 2 = No Tx → Tx; Group 3 = Tx → No Tx; Group 4 = Tx. Assessments included stretched penile length and standardized (International Index of Erectile Function [IIEF]) and non‐standardized questionnaires. Results A total of 82 men were enrolled (mean age 58.6 years) with 9‐month data available in 45 of the men. Baseline characteristics were similar among the cohorts. Comparing Group 1 and Group 4 (respectively), notable differences included: IIEF Erectile Function domain (IIEF‐EF) score (−8 vs −0.5; P = 0.16), penile length (−0.1 vs +1.7 cm; P < 0.01), intracavernosal injection use (86% vs 14%; P < 0.01), Sexual Encounter Profile (SEP) Question 2 (50% vs 100%; P < 0.01), SEP Question 3 (33% vs 100%; P < 0.01). Men who crossed over to Tx (Group 2) failed to achieve equivalent improvements in length (+0.5 cm) or sexual function (IIEF‐EF score −6) compared to men treated early (Groups 3 and 4). Those who crossed over to no treatment after initial treatment (Group 3) experienced preserved length (+1.8 cm), and erectile function (IIEF‐EF score +0) despite therapy discontinuation. Conclusions Use of RxPTT beginning 1 month post‐prostatectomy results in improved penile length and erectile function, with benefits maintained after discontinuing therapy. If confirmed, these results represent the first postoperative therapy shown in a RCT to improve erectile function post‐prostatectomy. External validation is warranted.
Higher systolic blood pressure in early‐mid adulthood is associated with poorer cognitive performance in those with a dominantly inherited Alzheimer's disease mutation but not in non‐carriers. Results from the DIAN study
Xu, Ying , Aung, Htein Linn , Chhatwal, Jasmeer P. , Day, Gregory S. , Fagan, Anne M. , Farlow, Martin R. , Gordon, Brian A. , Kehoe, Patrick G. , Xiong, Chengjie , Mori, Hiroshi , Morris, John C. , Wharton, Whitney , Humburg, Peter , Peters, Ruth , (DIAN), Dominantly Inherited Alzheimer Network, Vöglein, Jonathan , Peters, Ruth , Gordon, Brian A , Day, Gregory S , Vöglein, Jonathan , Xiong, Chengjie , Morris, John C , Bateman, Randall J. , Brooks, William S. , Schofield, Peter R. , (DIAN), Dominantly Inherited Alzheimer Network

Mayo Clinic

Alzheimer's & Dementia | April 23, 2023 | Volume: 19 | Issue: 11 | Pages: 4999-5009

10.1002/alz.13082 | PMID 37087693 Get It

AbstractBACKGROUNDThe Dominantly Inherited Alzheimer Network (DIAN) is a longitudinal observational study that collects data on cognition, blood pressure (BP), and other variables from autosomal‐dominant Alzheimer's disease mutation carriers (MCs) and non‐carrier (NC) family members in early to mid‐adulthood, providing a unique opportunity to evaluate BP and cognition relationships in these populations.METHODWe examined cross‐sectional and longitudinal relationships between systolic and diastolic BP and cognition in DIAN MC and NC.RESULTSData were available from 528 participants, who had a mean age of 38 (SD = 11) and were 42% male and 61% MCs, at a median follow‐up of 2 years. Linear‐multilevel models found only cross‐sectional associations in the MC group between higher systolic BP and poorer performance on language (β = −0.181 [−0.318, −0.044]), episodic memory (−0.212 [−0.375, −0.049]), and a composite cognitive measure (−0.146 [−0.276, −0.015]). In NCs, the relationship was cross‐sectional only and present for language alone.DISCUSSIONHigher systolic BP was cross‐sectionally but not longitudinally associated with poorer cognition, particularly in MCs. BP may influence cognition gradually, but further longitudinal research is needed.
Novel initiatives are always welcome
Jaffe, Allan S. , Jaffe, Allan S.

Mayo Clinic

European Heart Journal: Acute Cardiovascular Care | April 22, 2023 | Volume: 12 | Issue: 6 | Pages: 372-373

10.1093/ehjacc/zuad044 | PMID 37086470 Get It

εγ-Thalassemia, a New Hemoglobinopathy Category
Oliveira, Jennifer L. , Thompson, Christineil , Saravanaperumal, Siva Arumugam , Koganti, Tejaswi , Jenkinson, Garrett , Hein, Molly S., Kohorst, Mira A. , Hasadsri, Linda , Nguyen, Phuong L., Matern, Dietrich , Kipp, Benjamin R. , Klee, Eric W. , Wieben, Eric D. , Hoyer, James D., Rangan, Aruna , Thompson, Christineil H

Mayo Clinic

Clinical Chemistry | April 22, 2023 | Volume: 69 | Issue: 7 | Pages: 711-717

10.1093/clinchem/hvad038 | PMID 37086467 Get It

Abstract Background Large β-globin gene cluster deletions (hereditary persistence of fetal hemoglobin [Hb] or β-, δβ-, γδβ-, and ϵγδβ-thalassemia), are associated with widely disparate phenotypes, including variable degrees of microcytic anemia and Hb F levels. When present, increased Hb A2 is used as a surrogate marker for β-thalassemia. Notably, ϵγδβ-thalassemias lack the essential regulatory locus control region (LCR) and cause severe transient perinatal anemia but normal newborn screen (NBS) results and Hb A2 levels. Herein, we report a novel deletion of the ϵ, Aγ, Gγ, and ψβ loci with intact LCR, δ-, and β-regions in 2 women and newborn twins. Methods Capillary electrophoresis (CE), high-performance liquid chromatography (HPLC), DNA sequencing, multiplex ligation-dependent probe amplification (MLPA), gap-polymerase chain reaction (gap-PCR), and long-read sequencing (LRS) were performed. Results NBS showed an Hb A &gt; Hb F pattern for both twins. At 20 months, Hb A2 was increased similarly to that in the mother and an unrelated woman. Unexplained microcytosis was absent and the twins lacked severe neonatal anemia. MLPA, LRS, and gap-PCR confirmed a 32 599 base pair deletion of ϵ (HBE1) through ψβ (HBBP1) loci. Conclusions This deletion represents a hemoglobinopathy category with a distinct phenotype that has not been previously described, an ϵγ-thalassemia. Both the NBS Hb A &gt; F pattern and the subsequent increased Hb A2 without microcytosis are unusual. A similar deletion should be considered when this pattern is encountered and appropriate test methods selected for detection. Knowledge of the clinical impact of this new category will improve genetic counselling, with distinction from the severe transient anemia associated with ϵγδβ-thalassemia.
Efficacy of first‐line checkpoint inhibitors in combination with chemotherapy in high‐grade extrapulmonary metastatic neuroendocrine carcinomas
Gile, Jennifer , Leventakos, Konstantinos , Starr, Jason S. , Eiring, Rachel A. , Hobday, Timothy J. , Gile, Jennifer Jane , McGarrah, Patrick W. , Eiring, Rachel A , Sonbol, Mohamad Bassam , Hálfdánarson, Þorvarður R.

Mayo Clinic

Journal of Neuroendocrinology | April 22, 2023 | Volume: 35 | Issue: 5 | Pages: No page available

10.1111/jne.13283 | PMID 37229903 Get It

Abstract Poorly differentiated extrapulmonary neuroendocrine carcinomas (EP NECs) are aggressive cancers characterized by a high Ki‐67 index, rapid tumor growth and poor survival, and are subdivided into small and large cell carcinoma. For small cell carcinoma of the lung, a pulmonary NEC, the combination of cytotoxic chemotherapy (CTX) and a checkpoint inhibitor (CPI) is considered standard therapy and superior to CTX alone. EP NECs are typically treated with platinum‐based regimens, some clinicians have adopted the addition of a CPI to CTX based on data from trials in patients with small cell carcinoma of the lung. In this retrospective study of EP NECs, we report 38 patients treated with standard first‐line CTX and 19 patients treated with CTX plus CPI. We did not observe any additional benefit of adding CPI to CTX in this cohort.
Impact of a Co-curricular Poverty Simulation on Pharmacy Students’ Socioeconomic and Patient Advocacy Attitudes and Beliefs
Kelsch, Michael P. , Thompson, Sara, Skoy, Elizabeth T.

Mayo Clinic

Journal of Pharmacy Technology | April 22, 2023 | Volume: 39 | Issue: 3 | Pages: 110-116

10.1177/87551225231167294 | PMID 37323763 Get It

Background: Pharmacists are well-positioned to assist patients facing poverty with financial and well-being resource navigation. Pharmacy educators must find avenues for students that foster awareness of applicable challenges encountered by economically disadvantaged patients. Objective: This study examines the impact of a poverty simulation on pharmacy students’ socioeconomic and patient advocacy attitudes and beliefs. Methods: Third year professional pharmacy students participated in the Community Action Poverty Simulation (CAPS). Students were asked to voluntarily complete a survey prior to and following their participation. The survey was based upon a combination of 3 previously validated survey tools: Attitudes Toward Poverty (ATP) scale, Medical Student Attitudes Toward the Underserved (MSATU), and the Locus of Control Scale (LCS). Students also responded to open-ended questions postsimulation. Results: Forty of the 74 students completed both the presimulation and postsimulation surveys. Significant changes were seen in a matched sample analysis for 17 of 49 survey questions. Prominent differences (decreasing agreement) came from the statements: “An able-bodied person collecting welfare is ripping off the system” and “Welfare makes people lazy”; and increasing agreement that “I feel personally responsible for providing medical care to the needy.” Open-ended survey responses reflected a greater understanding of time and effort needed to locate and navigate available resources, and challenges such as adhering to medication regimens due to inability to pay. Conclusion: A poverty simulation, such as CAPS, is an effective method to encourage pharmacy students to reflect on their future impact toward patients facing the challenges of poverty. The shift in students’ attitudes and beliefs on various measures revealed that the simulation had an impact on altering perceptions for those with low socioeconomic status.
Early PSA Decline after Starting Second-Generation Hormone Therapy in the Post-Docetaxel Setting Predicts Cancer-Specific Survival in Metastatic Castrate-Resistant Prostate Cancer
Joshi, Vidhu B. , Gopalakrishna, Ajay , Haloi, Rimki , Bold, Michael S., Bryce, Alan H. , Karnes, R. Jeffrey , Kwon, Eugene D., Andrews, Jack R. , Bryce, Alan H , Ahmed, Mohamed E. , Lee, Matthew , Mahmoud, Ahmed , Bole, Raevti , Kendi, A. Tuba , Childs, Daniel S.

Mayo Clinic

No container title available | April 21, 2023 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-2819133/v1 Get It

Abstract Background The objective of this study was to evaluate the prognostic value of early PSA decline following initiation of second-generation hormone therapy (2nd HT), namely abiraterone acetate or enzalutamide, in patients with taxane-refractory metastatic castrate-resistant prostate cancer (mCRPC) and evaluate utility of this metric in informing intensified surveillance/imaging protocols. Methods We retrospectively identified 75 mCRPC patients treated with 2nd HT following docetaxel failure (defined as PSA rise and radiographic progression). Patients were categorized patients into two cohorts based on the first PSA within 3 months after initiation of therapy: PSA reduction ≥ 50% (Group A) and PSA reduction < 50% (Group B). The primary endpoint was cancer-specific mortality (CSM). The secondary endpoint was radiographic disease progression (rDP) on 2nd HT. In univariate and multivariate analyses, we investigated factors associated with rPD and CSM. Results We included 75 patients (52 in Group A, 23 in Group B) in the analytic cohort. Baseline clinico-demographic characteristics, including median age, primary Gleason score risk group, median pre-treatment PSA, disease burden, site of metastases, and pre-treatment ECOG score were not statistically different between the two groups. Median follow up time was 30 months and the median time to radiographic disease progression was 28.1 and 12.5 months (p = 0.002) in cohorts A and B, respectively. On univariate and multivariate analyses, both PSA reduction ≥ 50% and volume of metastatic disease were significantly associated with a decreased risk of radiographic disease progression (HR 0.41, 95% CI 0.21–0.80, p = 0.0113) as well as a decreased risk of cancer-specific mortality (HR 0.29, 95% CI 0.09–0.87, p = 0.0325). Conclusion PSA reduction ≥ 50% within 3 months of starting 2nd HT was associated with significantly improved radiographic disease progression-free survival and 3-year cancer-specific mortality. This suggests using PSA 50%-decline metric in surveillance patients with on 2nd HT and identifies patients who require further evaluation with imaging.
Teaching NeuroImages: Spinal xanthomatosis
Wingerchuk, Dean M. , Dhamija, Radhika , Dhamija, Radhika , Valencia-Sánchez, Cristina

Mayo Clinic

Neurology | April 21, 2023 | Volume: 100 | Issue: 16_supplement_1 | Pages: No page available

10.1212/wnl.0000000000207028 Get It